BNP Paribas cuts DSM-Firmenich stock to Neutral at EUR 100

Published on 10/14/2026 at 09:13 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

DSM-Firmenich repurchased 7,169,147 shares for EUR 540 million. A planned 2.60 percent cut reshapes DSM-Firmenich stock by 2027.

Capital and valuation markers

The company completed a EUR 540 million repurchase program on October 1, 2026.
BNP Paribas assigned a EUR 100 target on October 2, 2026.
Market capitalization stood at EUR 25.6 billion on October 13, 2026.
The planned capital reduction represents 2.60 percent of issued shares.

Bauhaus-Poster mit geometrischen Formen, Molekül und Schriftzug SCIENCE — dsm-firmenich AG (ISIN CH1216478797) erscheint als geometrisches Bauhaus-Poster mit Molekülformen und dem Wort SCIENCE, Illustration mit AI erstellt.

BNP Paribas downgraded DSM-Firmenich stock from Outperform to Neutral and set a EUR 100 price target on October 2, 2026, according to Markets Insider. The rating action followed a EUR 540 million share repurchase completed one day earlier.

Three dated corporate markers

On July 30, 2026, DSM-Firmenich reported second-quarter revenue of EUR 2.39 billion, while adjusted EBITDA reached EUR 466 million with a 19.50 percent margin, according to TickerLandia.

On October 1, 2026, the company said it had completed the EUR 540 million repurchase program. The program covered 7,169,147 shares at an average price of EUR 75.32, according to DSM-Firmenich.

On October 2, 2026, BNP Paribas moved the rating to Neutral from Outperform and named EUR 100 as its target, as Markets Insider reported.

What does the capital action change?

DSM-Firmenich intends to cancel 6,488,446 repurchased shares by the end of the first quarter of 2027, reducing issued shares from 253,626,947 to 247,138,501, according to DSM-Firmenich. The planned reduction is 2.60 percent of issued shares and provides a concrete capital-allocation reference for the EUR 100 target.

Capital and valuation markers

DSM-Firmenich had a market capitalization of EUR 25.6 billion on October 13, 2026. The same market snapshot placed the 52-week range at EUR 55.22 to EUR 103.80, leaving the valuation close to the upper end of that span while BNP Paribas used EUR 100 as its target.